Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3073% above fair value
$122.86+1.94 (+1.60%)
Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –
Haemonetics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Haemonetics's operating income for the twelve months ending Jun 27, 2026 was $160.32M, down 32.0% year over year. For fiscal 2026 it was $156.73M, down 29.3% from the year before. The highest annual figure on record is $221.82M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $156.73M | -29.3% |
| FY2025 | Mar 29, 2025 | $221.82M | +34.5% |
| FY2024 | Mar 30, 2024 | $164.88M | +5.7% |
| FY2023 | Apr 1, 2023 | $156.03M | +93.2% |
| FY2022 | Apr 2, 2022 | $80.75M | -10.0% |
| FY2021 | Apr 3, 2021 | $89.75M | -13.2% |
| FY2020 | Mar 28, 2020 | $103.35M | +23.7% |
| FY2019 | Mar 30, 2019 | $83.55M | +48.8% |
| FY2018 | Mar 31, 2018 | $56.16M | – |
| FY2017 | Apr 1, 2017 | -$19.38M | – |
| FY2016 | Apr 2, 2016 | -$43.94M | -208.4% |
| FY2015 | Mar 28, 2015 | $40.54M | -12.7% |
| FY2014 | Mar 29, 2014 | $46.43M | -17.7% |
| FY2013 | Mar 30, 2013 | $56.44M | -36.4% |
| FY2012 | Mar 31, 2012 | $88.76M | -19.7% |
| FY2011 | Apr 2, 2011 | $110.55M | +32.7% |
| FY2010 | Apr 3, 2010 | $83.28M | -2.7% |
| FY2009 | Mar 28, 2009 | $85.57M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $57.46M | +6.7% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | -$23.03M | -132.3% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $67.40M | +14.2% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $58.49M | +13.1% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $53.87M | +35.5% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $71.34M | +138.2% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $59.03M | +28.4% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $51.70M | +46.4% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $39.76M | -25.9% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $29.94M | -15.1% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $45.98M | +6.2% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $35.30M | -24.5% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $53.66M | +74.4% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $35.26M | +83.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $43.28M | +21.4% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $46.73M | +90.7% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $30.77M | +2113.5% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $19.20M | – |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $35.65M | -11.8% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $24.51M | -58.3% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $1.39M | -88.1% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | -$21.18M | -181.4% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $40.43M | -1.2% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $58.78M | +18.2% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $11.72M | – |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $26.01M | +9.0% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $40.91M | +44.4% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $49.74M | +90.7% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | -$13.30M | -351.3% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $23.86M | +67.1% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $28.32M | +2695.7% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $26.08M | +7.5% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $5.29M | -68.1% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $14.28M | – |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $1.01M | -95.2% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $24.26M | -2.2% |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $16.61M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | -$57.51M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $21.21M | – |
| Q2 FY2017CQ3 2016 | Oct 1, 2016 | $24.79M | – |
See a number that looks wrong?